1. Immunosuppression: evolution in practice and trends, 1993–2003;Shapiro;Am J Transplant,2005
2. Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory;Uber;J Heart Lung Transplant,2009
3. European Medicines Agency. Committee for Human Medicinal Products. Questions & Answers: positions on specific questions addressed to the Pharmacokinetics Working Party. EMA/618604/2008 Rev 5. September 2012.
4. Health Canada. Guidance document: comparative bioavailability standards: formulations used for systemic effects. Ottawa, Ontario: February 2012.
5. Therapeutic drug monitoring of immunosuppressant drugs in clinical practice;Kahan;Clin Ther,2002